|
GB9801398D0
(en)
|
1998-01-22 |
1998-03-18 |
Anggard Erik E |
Chemical compounds
|
|
IT1301759B1
(it)
*
|
1998-06-19 |
2000-07-07 |
Nicox Sa |
Sali nitrati di farmaci antiipertensivi
|
|
IT1311923B1
(it)
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
IE20000052A1
(en)
*
|
1999-04-29 |
2000-11-29 |
Russinsky Ltd |
Nitric acid salts of B-blockers
|
|
IT1314184B1
(it)
*
|
1999-08-12 |
2002-12-06 |
Nicox Sa |
Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
|
|
US6465463B1
(en)
|
1999-09-08 |
2002-10-15 |
Nitromed, Inc. |
Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
|
|
DE60042611D1
(de)
|
1999-10-29 |
2009-09-03 |
Nitromed Inc |
Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen
|
|
US7537785B2
(en)
|
1999-10-29 |
2009-05-26 |
Nitromed, Inc. |
Composition for treating vascular diseases characterized by nitric oxide insufficiency
|
|
US7235237B2
(en)
|
1999-10-29 |
2007-06-26 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
US7708989B2
(en)
|
1999-10-29 |
2010-05-04 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
JP2003523958A
(ja)
|
1999-12-23 |
2003-08-12 |
ニトロメド インコーポレーテッド |
ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
|
|
WO2001061043A2
(en)
|
2000-02-16 |
2001-08-23 |
Illumina, Inc. |
Parallel genotyping of multiple patient samples
|
|
EP1301500B1
(en)
|
2000-06-22 |
2007-11-21 |
Nitromed, Inc. |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
AU5939901A
(en)
*
|
2000-10-27 |
2002-05-06 |
Nitromed Inc |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
EP1219306A1
(en)
|
2000-12-29 |
2002-07-03 |
Nicox S.A. |
Compositions comprising cyclodextrins and NO- releasing drugs
|
|
WO2002087508A2
(en)
|
2001-05-02 |
2002-11-07 |
Nitromed, Inc. |
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
JP2005519928A
(ja)
|
2002-02-04 |
2005-07-07 |
ハース，ベルナー |
Ｃｏ放出能力を有する化合物の投与によって哺乳動物を治療する方法と、ｃｏ放出能力を有する化合物ならびにその医薬組成物
|
|
WO2003069333A1
(en)
|
2002-02-14 |
2003-08-21 |
Illumina, Inc. |
Automated information processing in randomly ordered arrays
|
|
EP1539134A4
(en)
|
2002-06-11 |
2007-04-11 |
Nitromed Inc |
SELECTIVE INHIBITORS OF CYCLOOXIGENASE-2 NITROSIS AND / OR NITROSYLES, COMPOSITIONS AND METHODS OF USE
|
|
US20060247216A1
(en)
*
|
2002-10-25 |
2006-11-02 |
Haj-Yehia Abdullah I |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
|
AU2003283789A1
(en)
*
|
2002-11-22 |
2004-06-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-blockers having antioxidant and nitric oxide-donor activity
|
|
EP1578413A2
(en)
*
|
2002-11-29 |
2005-09-28 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Ace-inhibitors having antioxidant and no-donor activity
|
|
US20070207217A1
(en)
*
|
2003-02-03 |
2007-09-06 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO
|
|
US7166638B2
(en)
|
2003-05-27 |
2007-01-23 |
Nicox S.A. |
Statin derivatives
|
|
US7169805B2
(en)
*
|
2003-05-28 |
2007-01-30 |
Nicox S.A. |
Captopril derivatives
|
|
MXPA05013771A
(es)
*
|
2003-06-19 |
2006-03-08 |
Nicox Sa |
Derivados de enalapril-nitroxiderivados y compuestos relacionados como inhibidores de la enzima que convierte la angiotensina para el tratamiento de enfermedades cardiovasculares.
|
|
WO2005018561A2
(en)
*
|
2003-08-20 |
2005-03-03 |
Nitromed, Inc. |
Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
|
|
BRPI0417182A
(pt)
*
|
2003-12-02 |
2007-03-06 |
Nicox Sa |
composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica
|
|
HRP20070283T3
(en)
*
|
2003-12-02 |
2007-11-30 |
Nicox S.A. |
Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
|
|
KR100850133B1
(ko)
*
|
2004-01-05 |
2008-08-04 |
니콕스 에스. 에이. |
프로스타글란딘 나이트로옥시 유도체
|
|
JP2008506716A
(ja)
*
|
2004-07-16 |
2008-03-06 |
ニトロメッド インコーポレーティッド |
心不全に関連する組成物および方法
|
|
JP2008510755A
(ja)
|
2004-08-25 |
2008-04-10 |
アクテリオン ファーマシューティカルズ リミテッド |
ビシクロノネン誘導体
|
|
US20080300292A1
(en)
*
|
2004-11-08 |
2008-12-04 |
Nitromed, Inc |
Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders
|
|
EP1846380A4
(en)
*
|
2005-01-21 |
2010-02-17 |
Nicox Sa |
HETEROCYCLIC NITROGEN MONOXIDE DONOR COMPOSITIONS CONTAINING CARDIOVASCULAR COMPOUNDS, AND METHODS OF USING THE SAME
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
KR100963455B1
(ko)
*
|
2005-05-27 |
2010-06-18 |
액테리온 파마슈티칼 리미티드 |
신규한 피페리딘 카르복실산 아미드 유도체
|
|
WO2007000641A2
(en)
*
|
2005-06-29 |
2007-01-04 |
Pfizer Inc. |
Prostaglandin derivatives
|
|
WO2007045551A2
(en)
*
|
2005-10-18 |
2007-04-26 |
Nicox S.A. |
Renin inhibitors nitroderivatives
|
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
|
JP2009526767A
(ja)
|
2006-02-02 |
2009-07-23 |
アクテリオン ファーマシューティカルズ リミテッド |
新規二級アミン
|
|
CA2634473A1
(en)
*
|
2006-02-17 |
2007-08-30 |
Nitromed, Inc. |
Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
|
|
TW200800897A
(en)
*
|
2006-03-08 |
2008-01-01 |
Actelion Pharmaceuticals Ltd |
New amines
|
|
JP2007275193A
(ja)
*
|
2006-04-04 |
2007-10-25 |
Fujifilm Corp |
光プローブおよび光断層画像化装置
|
|
CA2652135A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Nitromed, Inc. |
Solid dosage formulations of hydralazine compounds
|
|
RU2322972C1
(ru)
*
|
2006-09-12 |
2008-04-27 |
Илья Николаевич Медведев |
Способ профилактики тромбозов у больных артериальной гипертонией с метаболическим синдромом
|
|
TW200831079A
(en)
*
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Angiotensin II receptor antagonists
|
|
FR2921365B1
(fr)
*
|
2007-09-21 |
2012-10-12 |
Servier Lab |
Nouveaux sels d'addition d'inhibiteurs d'enzyme de conversion de l'angiotensine a des acides donneurs de no, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
CN102015682B
(zh)
*
|
2008-05-05 |
2014-07-16 |
埃科特莱茵药品有限公司 |
作为肾素抑制剂的3,4-取代的哌啶衍生物
|
|
WO2010116270A1
(en)
|
2009-04-10 |
2010-10-14 |
Pfizer Inc. |
Ep2/4 agonists
|
|
WO2011160974A2
(en)
|
2010-06-21 |
2011-12-29 |
Nicox S.A. |
Statin derivatives
|
|
PT2699242T
(pt)
|
2011-04-19 |
2018-01-22 |
Alfama Inc |
Moléculas de libertação de monóxido de carbono e utilizações das mesmas
|
|
ES2628634T3
(es)
|
2011-07-21 |
2017-08-03 |
Alfama, Inc. |
Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
|
|
CA2897571C
(en)
|
2013-01-21 |
2018-12-18 |
Apparao Satyam |
Nitric oxide releasing prodrugs of therapeutic agents containing at least one carboxylic acid group
|
|
US11058691B2
(en)
|
2016-11-08 |
2021-07-13 |
Nicox S.A. |
Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
|
|
SMT202400527T1
(it)
|
2019-07-01 |
2025-01-14 |
Tonix Pharma Ltd |
Anticorpi anti-cd154 e loro usi
|
|
CA3207098A1
(en)
|
2021-01-06 |
2022-07-14 |
Tonix Pharma Limited |
Methods of inducing immune tolerance with modified anti-cd154 antibodies
|
|
WO2025248134A1
(en)
|
2024-05-31 |
2025-12-04 |
Tonix Pharma Limited |
Treatment methods comprising administration of modified cd154 antibodies
|